Published in Obesity and Diabetes Week, October 8th, 2007
"In addition, they are considered as an attractive alternative to classical basal-bolus therapy as fewer daily injections are required. Premixed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.